Backpack Stakes Token to Offer Users Access to Equity
Backpack is launching a year-long staking program that could convert a portion of its tokens into a 20% equity stake ...
Using Index Level To Adjust Risk
Using Index Level to adjust risk lets you scale exposure in line with market momentum, maintaining a balanced, rules-based approach.
27,393 articles
Trump Says Will Fair: AI Data Centers Must Pay for Power
Former President Trump claimed AI data centers should pay for their own electricity in a recent address, triggering a...
Best Aerospace Defense Stocks to Watch Right Now in 2026
Global security priorities and rising defense budgets spotlight the best aerospace defense stocks. Here’s a timely lo...
Behind Joby’s Massive 2026 Plans: A Closer Look for Investors
As Joby Aviation gears up for commercial flights in 2026, investors are weighing a bold ramp in production, regulator...
I’ve Been Advising Wealthy Families, Time for 100-Year Plans
Wealthy family offices are reassessing multi-generational real estate bets as the market shifts and the Great Wealth ...
Something’s Different About America: Drilling Shifts Wealth
America’s energy chart has flipped from import-reliant to resilient. This report explains how something’s different a...
Karat Packaging Stock Soared: A Closer Look at the Rally
When a packaging company posts stronger results, investors take notice. This piece explains why karat packaging stock...
Dalio Sees Pattern That China Weighs on U.S. Economy
A 2,000-year GDP chart is fueling debate about long-run shifts in economic power. Dalio’s pattern idea is driving fre...
Stablecoins Just Lost Battle: Insurance Winds Shift
Regulators are tightening what on-chain dollars can be insured, a move that could redefine how stablecoins are used v...
Protesters Rally Outside OpenAI Over Crypto and AI Safety
In San Francisco, activists and industry critics gathered outside AI hubs to demand a pause on fast-paced development...
Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Chewy Down This Year: A Smart Buy for Long-Term Investors
Chewy has faced a rough year, with shares falling and growth challenges ahead. Yet, a closer look under the hood show...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status